(Q35974290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Part II: Vaccines for haematological malignant disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Susanna Mandruzzato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Simone Mocellin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Carlo Riccardo Rossi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

727-737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Challenges in treating hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Donor lymphocyte infusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Monoclonal antibody therapy for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

The promise of cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

1 reference

7 January 2021

B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Generation of immunostimulatory dendritic cells from the malignant clone in patients with juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Anti-idiotype vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

In-vivo immune responses to idiotypic VH complementarity-determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

A phase II study of heat shock protein-peptide complex-96 vaccine therapy in patients with indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Deletion of idiotype (Id)-specific T cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

CD91: a receptor for heat shock protein gp96

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

The use of dendritic cells in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Molecular oncology in the post-genomic era: the challenge of proteomics.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

Cancer vaccines: between the idea and the reality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901649-3

7 January 2021

10.1016/S1470-2045(04)01649-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15581544%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference